The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

The nominee for HHS secretary hedged this answers to questions about vaccine safety and efficacy at his second confirmation hearing today.

The HYPERION study was evaluating Winrevair in recently diagnosed adults with pulmonary arterial hypertension.

Some regulatory changes are already set to happen this year, but reduced regulation under the new administration could have a ripple effects in healthcare. Meanwhile, artificial intelligence is likely ...

After several days of worry that the global AIDS program might come to abrupt end, Secretary of State Marco Rubio issued a ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

At today's confirmation hearing, Democratic senators were skeptical of the HHS Secretary nominee Robert F. Kennedy Jr.'s ...

Robert F. Kennedy Jr., the HHS secretary nominee, has said he is not antivaccine, but he has a track record of casting doubt ...

The survey also showed that high drug costs and artificial intelligence are topmost among the respondent’s concerns.

In this new role, Flaster will lead Cigna Healthcare’s clinical organization, focusing on initiatives to improve customer ...